iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,038.8
(0.41%)
Feb 17, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
1,1250%₹420.5 0%1,560--
1,1250%₹400.6 0%1,580--
00%₹331.55 0%1,640--
3750%₹281.95 0%1,680₹0.75 -25%13,1250%
3,0000%₹339 97.09%1,700--
1,1250%₹238.55 0%1,720₹1.1 0%63,3750%
--1,740₹1.4 0%22,8750%
--1,760₹1.2 0%22,1250%
4,1250%₹194.55 0%1,780₹1.3 0%22,1250%
7,1250%₹224 0%1,800₹1.4 -3.44%1,07,625-0.69%
6,0000%₹131.95 0.76%1,820₹1.5 -3.22%45,0000%
7,5000%₹123.75 0%1,840₹1.95 2.63%30,750-10.86%
21,0000%₹164.05 0%1,860₹2.05 -8.88%34,125-37.24%
18,7500%₹137 0%1,880₹2.3 -19.29%61,125-15.54%
49,1253.14%₹139.3 -2.27%1,900₹3 -17.8%3,21,375-1.72%
24,7500%₹118.3 0%1,920₹4.1 -21.15%91,875-7.89%
42,0000%₹104.45 -0.66%1,940₹6 -16.66%1,60,500-7.75%
1,35,750-3.97%₹85.25 -4.58%1,960₹7.85 -24.51%3,14,62523.02%
74,6251.01%₹67.9 -5.95%1,980₹12 -20%1,12,8750%
3,51,000-9.03%₹49.05 -15.57%2,000₹18.8 -10.04%1,48,500-1.24%
1,33,500-22.60%₹38.1 -16.99%2,020₹26.45 -6.37%69,000-8.45%
4,18,12517.36%₹28.35 -18.76%2,040₹36.35 -4.46%93,0005.53%
1,33,5003.79%₹19.65 -26.26%2,060₹44.75 -8.48%1,09,500-1.68%
1,02,375-25%₹13.8 -28.12%2,080₹57.55 -5.65%7,875-38.23%
6,39,000-11.34%₹9.3 -36.51%2,100₹69 -9.68%22,875-7.57%
1,99,875-5.49%₹6.75 -32.83%2,120₹96.3 0%10,8750%
1,71,7504.09%₹4.2 -39.56%2,140₹113.1 0%3,3750%
1,23,3753.45%₹2.95 -43.8%2,160₹149.25 0%2,2500%
63,00011.25%₹2.2 -42.85%2,180₹140.45 -3.27%3,75011.11%
1,68,750-4.66%₹1.6 -46.66%2,200₹160.15 -1.95%6,750-14.28%
16,500-6.38%₹1.75 -20.45%2,220₹240 0%3750%
38,2500%₹1.25 -26.47%2,240₹209.85 0%1,1250%
375-50%₹0.95 -32.14%2,260--
16,8750%₹1 33.33%2,280₹287.35 0%1,1250%
16,875-11.76%₹0.5 -33.33%2,300₹310 0%38,2500%
47,6250%₹0.65 0%2,320--
12,0000%₹0.2 -50%2,360--
31,1250%₹0.1 -33.33%2,400--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.